New drug regulation in Norway

The new regulation in Norway provides access to list of the groups of substances, that allows the government to a greater extent predefine newly developed drugs. In the list adopted as part of the regulation, 10 groups of substances are listed. These groups cover the vast majority of the newly developed psychotropic drugs that was uncovered since 2011.

According to Norwegian News Agency -ANB’s report, more than 25 new drugs have found their way to Norway this year. National Institute of Drug Abuse (SIRUS) does not expect a decline in the following year. A synthetic cannabis, called cathinones (mephedrone, MDPV), accounts for most of the increase.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.